Filing Flows

Filing Flows › MiniMed Group (MMED) › Q2 2026 › vs Q1 2026

MiniMed Group (MMED) Q2 2026 vs Q1 2026 (quarter over quarter)

MiniMed Group's revenue rose $6.0M (+0.7%) from $837M in Q1 2026 to $843M in Q2 2026. The biggest changes: Other −$15.0M (-68%); Consumables +$12.0M (+5%); CGM +$11.0M (+3%). Gross margin 55.2% against 57.3% (-2.2 pts).

MiniMed Group, Q2 2026: revenue $843M (+17% year over year), operating margin 0.6%, net earnings $0, operating cash flow −$49.0M. The chart draws each line against Q1 2026, the increases inside each band.

MiniMed Group: what changed, Q2 2026 vs Q1 2026MiniMed Group: what changed, Q2 2026 vs Q1 2026Net earnings$185MOther operating costs−$142MCash used in operations−$121MOperating cash sources−$117MOperating expenses−$113MOperating profit$98.0MPre-tax earnings$96.0MIncome tax−$89.0MWorking capital & other$68.0MCost of revenue$21.0M

Margins

Q2 2026Q1 2026Change
Gross margin55.2%57.3%-2.2 pts
Operating margin0.6%-11.1%+11.7 pts
Net margin0.0%-22.1%+22.1 pts

Every line

LineQ2 2026Q1 2026Change%
CGM$431M$420M$11.0M+3%
Consumables$261M$249M$12.0M+5%
Pumps$144M$145M−$1.0M-0.7%
Other$7.0M$22.0M−$15.0M-68%
Revenue$843M$837M$6.0M+0.7%
Gross profit$465M$480M−$15.0M-3%
Cost of revenue$378M$357M$21.0M+6%
Operating profit$5.0M−$93.0M$98.0M—
Operating expenses$460M$573M−$113M-20%
Pre-tax earnings$4.0M−$92.0M$96.0M—
Research & development$115M$99.0M$16.0M+16%
SG&A$312M$299M$13.0M+4%
Other operating costs$33.0M$175M−$142M-81%
Net earnings$0−$185M$185M—
Income tax$4.0M$93.0M−$89.0M-96%
Operating cash sources$100M$217M−$117M-54%
Depreciation & amortization$41.0M$39.0M$2.0M+5%
Share-based compensation$10.0M$8.0M$2.0M+25%
Cash used in operations$49.0M$170M−$121M-71%
Working capital & other$100M$32.0M$68.0M+212%

Questions

How much did MiniMed Group's revenue grow quarter over quarter in Q2 2026?

MiniMed Group's revenue rose $6.0M (+0.7%) from $837M in Q1 2026 to $843M in Q2 2026.

What drove MiniMed Group's revenue change in Q2 2026?

Other −$15.0M (-68%); Consumables +$12.0M (+5%); CGM +$11.0M (+3%).

Q2 2026 results → · Compare in the interactive Sankey →